Cargando…

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options

Hepatocellular cancer (HCC) is the most common primary liver cancer and the third leading cause of cancer-related death. Locoregional therapies, including transarterial embolization (TAE: bland embolization), chemoembolization (TACE), and radioembolization, have demonstrated survival benefits when t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pourbaghi, Miles, Haghani, Leila, Zhao, Ken, Karimi, Anita, Marinelli, Brett, Erinjeri, Joseph P., Geschwind, Jean-Francois H., Yarmohammadi, Hooman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377758/ https://www.ncbi.nlm.nih.gov/pubmed/37504345 http://dx.doi.org/10.3390/curroncol30070485

Ejemplares similares

Reducing Wait Times for Radiology Exams Around Holiday Periods: A Monte Carlo Simulation
por: Pisharody, Vivek A., et al.
Publicado: (2022)

Utilization of integrated angiography-CT interventional radiology suites at a tertiary cancer center
por: Erinjeri, Joseph P., et al.
Publicado: (2020)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
por: Jiang, Jianwen, et al.
Publicado: (2020)

Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
por: Jung, Joann, et al.
Publicado: (2022)

MRI assessment of hepatocellular carcinoma after locoregional therapy
por: Hussein, Rasha S., et al.
Publicado: (2019)

Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
por: Makary, Mina S, et al.
Publicado: (2021)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases
por: Ziv, Etay, et al.
Publicado: (2017)

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming
por: Wang, Xinyue, et al.
Publicado: (2020)

Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall Survival
por: Velayati, Sara, et al.
Publicado: (2023)

Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients
por: Sutton, Charles, et al.
Publicado: (2020)

Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
por: Inchingolo, Riccardo, et al.
Publicado: (2019)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
por: Dou, Qianhui, et al.
Publicado: (2022)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021)

The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
por: Brandi, Nicolò, et al.
Publicado: (2023)

Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2023)

Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
por: Young, Shamar, et al.
Publicado: (2023)

Glucose and Lactate Transport in Pancreatic Cancer: Glycolytic Metabolism Revisited
por: Cameron, Miles E., et al.
Publicado: (2018)

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
por: Marin, Daniel, et al.
Publicado: (2015)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival
por: Beal, Eliza W., et al.
Publicado: (2016)

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
por: Aly, Abdalla, et al.
Publicado: (2021)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma
por: Chen, Quan, et al.
Publicado: (2021)

Commentary: Mesothelioma … moving the needle on locoregional control has invited aggressive treatment options for limited distant metastases
por: Lanuti, Michael
Publicado: (2020)

METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma
por: Lin, Ye, et al.
Publicado: (2020)

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
por: Yutani, Shigeru, et al.
Publicado: (2017)

Histology of Hepatocellular Carcinoma: Association with Clinical Features, Radiological Findings, and Locoregional Therapy Outcomes
por: Park, Benjamin V., et al.
Publicado: (2019)

The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma
por: Singh, Prabhsimranjot, et al.
Publicado: (2020)

Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status
por: Qian, Kun, et al.
Publicado: (2020)

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
por: Han, Ji-Won, et al.
Publicado: (2021)

Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ueiklhppnhm8vv03lfq559r2qo